News Release

Glenn Foundation Discovery Award launched. Junior Faculty Grants and Postdoctoral Fellows funding also increased

AFAR and GFMR strengthen their long-time support of Aging Research

Grant and Award Announcement

American Federation for Aging Research

Santa Barbara, CA and New York, NY -- The Glenn Foundation for Medical Research (GFMR) and the American Federation for Aging Research (AFAR) are pleased to announce a new funding opportunity and increased funding for two other programs in 2023.

The Glenn Foundation Discovery Award has been created to support research projects with strong potential to develop pioneering discoveries to understanding the underlying mechanisms of biology that govern normal human aging and its related physiological decline. Relevant proposals from any branch of biology are eligible. 

Two three-year awards will be made in 2023, at the level of $525.000 total ($175,000 per year for three years).

“The Discovery Award specifically seeks to include principal investigators who have not been engaged in aging research, but whose research is relevant and could lead to novel approaches,” notes Mark Collins, President of the Glenn Foundation for Medical Research. 

GFMR is also furthering its commitment to aging and long-time collaboration with AFAR in 2023 by increasing the award amounts for the Research Grants for Junior Faculty, which will increase from $125,000 to $150,000, and the Postdoctoral Fellowships in Aging, which will increase from $60,000 to $75,000 each. 

“By supporting talented early career and established investigators, GMFR and AFAR initiatives have been instrumental in growing in the pipeline of researchers in aging,” notes AFAR Executive Director Stephanie Lederman, EdM. “This increased support will strengthen the field, translating research into interventions that lead to extended healthspan.”

For application guidelines, visit




About the Glenn Foundation for Medical Research - Founded by Paul F. Glenn in 1965, the mission of the Glenn Foundation for Medical Research is to extend the healthy years of life through research on mechanisms of biology that govern normal human aging and its related physiological decline, with the objective of translating research into interventions that will extend healthspan withlifespan. Learn more at

About AFAR - The American Federation for Aging Research (AFAR) is a national non-profit organization that supports and advances pioneering biomedical research that is revolutionizing how we live healthier and longer. For more than four decades, AFAR has served as the field’s talent incubator, providing more than $193 million to nearly 4350 investigators at premier research institutions to date—and growing. In 2022, AFAR is expected to award over $11,000,000 to more than 60 investigators. A trusted leader and strategist, AFAR also works with public and private funders to steer high quality grant programs and interdisciplinary research networks. AFAR-funded researchers are finding that modifying basic cellular processes can delay—or even prevent—many chronic diseases, often at the same time. They are discovering that it is never too late—or too early—to improve health. This groundbreaking science is paving the way for innovative new therapies that promise to improve and extend our quality of life—at any age. Learn more at or follow AFARorg on Twitter and Facebook and American Federation for Aging Research on LinkedIn.



Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.